These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Increased fibrinopeptide A after prothrombin complex concentrates. Viganó S; Cattaneo M; Gervasoni W; Mannucci PM Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400 [TBL] [Abstract][Full Text] [Related]
5. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]. Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666 [TBL] [Abstract][Full Text] [Related]
6. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863 [TBL] [Abstract][Full Text] [Related]
7. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients. Prentice CR Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428 [No Abstract] [Full Text] [Related]
8. Treatment of anti-factor VIII antibodies. Blatt PM; White GC; McMillan CW; Roberts HR Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of factor VIII: detection and treatment. Brettler DB Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576 [TBL] [Abstract][Full Text] [Related]
11. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies. Buchanan GR; Kevy SV Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653 [TBL] [Abstract][Full Text] [Related]
13. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases]. Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386 [TBL] [Abstract][Full Text] [Related]
14. The management of factor VIII inhibitors in non-hemophilic patients. Green D Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438 [TBL] [Abstract][Full Text] [Related]
15. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]
16. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A. Sullivan DW; Purdy LJ; Billingham M; Glader BE Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390 [TBL] [Abstract][Full Text] [Related]
17. Treatment of hemophilia. Rodeghiero F Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697 [TBL] [Abstract][Full Text] [Related]
19. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)]. Verroust F; Moussard C; Allain JP Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962 [TBL] [Abstract][Full Text] [Related]
20. New alternatives and strategies in the treatment of inhibitors. Hoyer LW Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]